Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date06 Nov 2018 |
100 Clinical Results associated with Jinling Pharmaceutical Co. Ltd. Fuzhou Meifeng Pharmace
0 Patents (Medical) associated with Jinling Pharmaceutical Co. Ltd. Fuzhou Meifeng Pharmace
100 Deals associated with Jinling Pharmaceutical Co. Ltd. Fuzhou Meifeng Pharmace
100 Translational Medicine associated with Jinling Pharmaceutical Co. Ltd. Fuzhou Meifeng Pharmace